AngioDynamics (ANGO)

12.20 -0.13  -1.05%  May 25, 11:00PM Go Pro
Watch this stock

AngioDynamics Beneish M-Score: -2.869

Get Interactive Chart for

View ANGO Beneish M-Score with YCharts Pro.




Start My 14-Day Free Trial We respect your privacy. We will never share your email address.
document.write('');

Access these YCharts Pro features:

  • Export any data you want
  • Save any chart as an image
  • Utilize advanced screener power
  • View 30 years of financial history
  • over 90 advanced calculations
  • Enjoy an advertising free experience
and much more...

ANGO Beneish M-Score Rankings

Overall 69th percentile 1154 of 3761
Sector 78th percentile 72 of 342 in Healthcare
Industry 79th percentile 13 of 62 in Medical Instruments & Supplies

ANGO Beneish M-Score Range, Past 5 Years

Minimum -2.869 May 2011
Maximum 5.826 May 2007
Average -0.9388

About Beneish M Score

The Beneish M Score helps to uncover companies who are likely to be manipulating their reported earnings. Companies with a higher score are more likely to be manipulators. This is a probabilistic model, so it will not detect manipulators with 100% accuracy.

The best cut-off point depends on the costs mistakenly classifying in one of two ways:

1) Classifying firm that is manipulating earnings as a non-manipulator (Type I error), and
2) Classifying a firm as a manipulator when it actually was not manipulating (Type II Error).

Here are optimal cut-offs according to Beneish, presented as the score followed by the cost of Type I error relative to cost of Type II error):

M Score HTML Table:

ScoreRelative Error Costs
(Type I:Type II)
M Score > -1.49 (10:1)
M Score > -1.78 (20:1)
M Score > -1.89 (40+:1)


Beneish excluded financial institutions from his sample when calculating the M-Score, so extreme care should be taken when looking at M-Scores of financial firms - their business models are different from the manufacturing and other service firms that Beneish used in his study.

If you want more details, here is the original Beneish M Score Paper, or you can learn about our calculation by clicking "Learn More" below.

Learn More

ANGO News

AngioDynamics Completes Acquisition of Navilyst Medical http://stks.co/3vuI $ANGO
about 5 days ago by evcgroup
AngioDynamics Shareholders Approve Share Issuance for Navilyst Medical Acquisition http://stks.co/3qGr $ANGO
about 12 days ago by evcgroup
RT @MedDevice ABC on Dr. Cunningham of @VeinClinics on the VenaCure 1470 for varicose veins bit.ly/VeinClinicsofAmericaBrentwood $ANGO
about 20 days ago by evcgroup
$ANGO filed latest Quarterly Report http://stks.co/3GyA
about 48 days ago by MarketBrief
$ANGO New 52 Week Low - Crossed daily lows support.
about 48 days ago by TradeIdeasQuant
AngioDynamics Goes Red
Apr 09, 12:00PM Fool
Listen to $ANGO Q3 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3E55
about 53 days ago by earningscast
AngioDynamics Receives FDA Clearance for NeverTouch Direct Procedure Kit to be Used With VenaCure EVLT System http://stks.co/2OQd $ANGO
about 103 days ago by evcgroup
AngioDynamics Launches DuraFlow 2 Chronic Hemodialysis Catheter http://stks.co/2InF $ANGO
about 109 days ago by evcgroup
$ANGO 200 Day SMA Cross - Price crossed below 200 day SMA (14.4842). Confirmed by volume.
about 117 days ago by TradeIdeasQuant
$ANGO Q3 adj-EPS from 9-11c to 7-9c, Q4 from 11-13c to 10-12c, FY12 from 41-45c to 38-42c
about 124 days ago by Street_Insider
$ANGO shares sink: cuts Q3, Q4, FY12 guidance
about 124 days ago by Street_Insider
$ANGO filed latest Quarterly Report http://stks.co/1ocw
about 142 days ago by MarketBrief
$ANGO filed latest Quarterly Report http://stks.co/1nMi
about 143 days ago by MarketBrief
Listen to $ANGO Q2 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/1nIm
about 143 days ago by earningscast
$ANGO Reports Q2 EPS $0.09 vs $0.12 Est; Revenues $58.10M vs $56.26M Est
about 143 days ago by Benzinga
AngioDynamics' new VenaCure 1470 in Houston http://stks.co/1PWW $ANGO
about 173 days ago by evcgroup
Listen to $ANGO at piper jaffray health care conference - live at 03:00 PM, ondemand after - http://stks.co/1KNG
about 179 days ago by earningscast
AngioDynamics Expands Senior Leadership Team $ANGO http://stks.co/11Gy
about 201 days ago by evcgroup
RT @EVCGroup RT @MedDevice Here's where varicose vein treatment is today, a solid summary in Vascular Disease Management goo.gl/j3Vk1 $ANGO
about 205 days ago by evcgroup
$ANGO filed latest Quarterly Report http://stks.co/ZxW
about 229 days ago by MarketBrief
$ANGO Reports Q1 EPS $0.08 vs $0.08 Est; Revenue $54.4M vs $53.86M Est; Announces Stock Repurchase Authorization of up to $20M
about 234 days ago by Benzinga
AngioDynamics $ANGO shares falling as FDA issues warning letter over NY plant inspection
about 271 days ago by Street_Insider
$NEOP Big Hedge funds need 2 buy & drive it up to $9,see how much Martin can lose! $CMN,$CALP,$ANGO,$OSUR,$DNDN,$PFE,$TEVA,$MRK,$JNJ,$NVS
about 355 days ago by funkybunch
After falling about 3% before the Nasdaq could halt, shares of $ANGO have bounced upon resumption, now down about 1.2% from today's close.
about 488 days ago by Street_Insider

Recent Quotes

Symbol Price Chg Chg % Market Cap
ANGO 12.20 -0.13 -1.05% 306.46M
ANGN 5.85 +0.20 +3.54% 22.93M
ANF 36.23 +0.94 +2.66% 3.069B
ANEN 19.05 +0.06 +0.32% 283.65M
ASPS 57.98 -1.04 -1.76% 1.352B
ASP 11.61 -0.05 -0.46%
ASNA 18.90 -0.02 -0.11% 2.896B
ASML 46.00 -0.22 -0.48% 19.03B
ASMI 35.28 -0.28 -0.79% 1.954B
ASM 1.24 -0.01 -0.72% 25.52M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close